Ryckie George Wade

Ryckie George Wade

Auto-generated profile, based on publicly available information

Ryckie George Wade

University of Leeds

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in The Lancet Psychiatry
Verified
Journal Article
Closed access
AVAravinthan Varatharaj
Aravinthan Varatharaj
NTNaomi Thomas
Naomi Thomas
MEMark A Ellul
Mark A Ellul
NDNicholas W S Davies
Nicholas W S Davies
TPThomas A Pollak
Thomas A Pollak
GPGordon Plant
Gordon Plant

23 June 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MGMichael C. Grant
Michael C. Grant
LGLuke Geoghegan
Luke Geoghegan
MAMarc Arbyn
Marc Arbyn
ZMZakaria Mohammed
Zakaria Mohammed
LMLuke McGuinness
Luke McGuinness
RWRyckie G. Wade
Ryckie G. Wade
To limit the spread of SARS-CoV-2, an evidence-based understanding of the symptoms is critical to inform guidelines for quarantining and testing. The most common features are purported to be fever and a new persistent cough, although the global prevalence of these symptoms remains unclear. The aim of this systematic review is to determine the prevalence of symptoms associated with COVID-19 worldwide. We searched PubMed, Embase, CINAHL, AMED, medRxiv and bioRxiv on 5th April 2020 for studies of adults (>16 years) with laboratory test confirmed COVID-19. No language or publication status restrictions were applied. Data were independently extracted by two review authors into standardised forms. All datapoints were independently checked by three other review authors. A random-effects model for pooling of binomial data was applied to estimate the prevalence of symptoms, subgrouping estimates by country. I2 was used to assess inter-study heterogeneity. Of 851 unique citations, 148 articles were included which comprised 24,410 adults with confirmed COVID-19 from 9 countries. The most prevalent symptoms were fever (78% [95% CI 75%-81%]; 138 studies, 21,701 patients; I2 94%), a cough (57% [95% CI 54%-60%]; 138 studies, 21,682 patients; I2 94%) and fatigue (31% [95% CI 27%-35%]; 78 studies, 13,385 patients; I2 95%). Overall, 19% of hospitalised patients required non-invasive ventilation (44 studies, 6,513 patients), 17% required intensive care (33 studies, 7504 patients), 9% required invasive ventilation (45 studies, 6933 patients) and 2% required extra-corporeal membrane oxygenation (12 studies, 1,486 patients). The mortality rate was 7% (73 studies, 10,402 patients). We confirm that fever and cough are the most prevalent symptoms of adults infected by SARS-CoV-2. However, there is a large proportion of infected adults which symptoms-alone do not identify.

1 January 2010
Verified
Journal Article
Open access
UJUsman Jaffer
Usman Jaffer
RWR G Wade
R G Wade
TGT Gourlay
T Gourlay
Patients subject to major surgery, suffering sepsis, major trauma, or following cardiopulmonary bypass exhibit a systemic inflammatory response. This inflammatory response involves a complex array of inflammatory polypeptide molecules known as cytokines. It is well accepted that the loss of local control of the release of these cytokines leads to systemic inflammation and potentially deleterious consequences including the Systemic Inflammatory Response Syndrome, Multi-Organ Dysfunction Syndrome, shock and death. The Medline database was searched for literature on mechanisms involved in the development of SIRS and potential targets for modifying the inflammatory response. We focus on the novel therapy of cytokine adsorption as a promising removal technology. Accumulating data from human studies and experimental animal models suggests that both pro- and anti- inflammatory cytokines are released following a variety of initiating stimuli including endotoxin release, complement activation, ischaemia reperfusion injury and others. Pro-and anti-inflammatory cytokines interact in a complex and unpredictable manner to influence the immune system and eventually cause multiple end organ effects. Cytokine adsorption therapy provides a potential solution to improving outcomes following Systemic Inflammatory Response Syndrome.

1 April 2018 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
RWRyckie G. Wade
Ryckie G. Wade
JWJames Watford
James Watford
JWJustin C.R. Wormald
Justin C.R. Wormald
RBRussell J. Bramhall
Russell J. Bramhall
AFAndrea Figus
Andrea Figus

8 July 2020 in Annals of Surgery
Verified
Journal Article
Open access
RWRyckie G. Msc Wade
Ryckie G. Msc Wade
NBNicholas E. Mbbs Burr
Nicholas E. Mbbs Burr
GMGordon MBBS McCauley
Gordon MBBS McCauley
GBGrainne Mb Bourke
Grainne Mb Bourke
OEOrestis Efthimiou
Orestis Efthimiou
Objective: There is uncertainty around preoperative skin antisepsis in clean surgery. Network meta-analysis provides more precise estimates than standard pairwise meta-analysis and can rank interventions by efficacy, to better inform clinical decisions. Background: Infection is the most common and costly complication of surgery. The relative efficacy of CHG and PVI based skin antiseptics in clean surgery remains unclear. Methods: We searched for randomized or nonrandomized studies comparing the effect of different preparations of CHG and PVI on the dichotomous outcome of surgical site infection. We included studies of adults undergoing clean surgery. We excluded studies concerning indwelling vascular catheters, blood sampling, combination antiseptics or sequential applications of different antiseptics. We performed a network meta-analysis to estimate the relative efficacy of interventions using relative risks (RR). Results: We included 17 studies comparing 5 antiseptics in 14,593 individuals. The overall rate of surgical site infection was 3%. Alcoholic CHG 4%–5% was ranked as the most effective antiseptic as it halved the risk of surgical site infection when compared to aqueous PVI [RR 0.49 (95% confidence interval 0.24, 1.02)] and also to alcoholic PVI, although uncertainty was larger [RR 0.51 (95% confidence interval 0.21, 1.27)]. Adverse events related to antiseptic application were only observed with patients exposed to PVI. Conclusions: Alcoholic formulations of 4%–5% CHG seem to be safe and twice as effective as PVI (alcoholic or aqueous solutions) in preventing infection after clean surgery in adults. Our findings concur with the literature on contaminated and clean-contaminated surgery, and endorse guidelines worldwide which advocate the use of alcoholic CHG for preoperative skin antisepsis. Registration: PROSPERO ID CRD42018113001.

2 November 2020 in JAMA Network Open
Verified
Journal Article
Closed access
PDF file
RWRyckie G. Wade
Ryckie G. Wade
TGTimothy T. Griffiths
Timothy T. Griffiths
RFRobert Flather
Robert Flather
NBNicholas E. Burr
Nicholas E. Burr
MTMario Teo
Mario Teo
GBGrainne Bourke
Grainne Bourke
Cubital tunnel syndrome is the second most common compressive neuropathy, affecting up to 6% of the population1 or 36 per 100 000 person-years.2 Surgical decompression of the cubital tunnel is the most effective treatment.3-5 Consequently, approximately 15 000 people across the UK6 and US7 undergo surgical decompression annually.